Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review

With the Food and Drug Administration designation in 2017 of 3,4-methylenedioxymethamphetamine (MDMA) as a breakthrough therapy in post-traumatic stress disorder and psilocybin in treatment-resistant depression, psychedelic drugs have continued to garner the attention of researchers and clinicians f...

Descripción completa

Detalles Bibliográficos
Autores principales: Fonseka, Lakshan N, Woo, Benjamin KP
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251361/
https://www.ncbi.nlm.nih.gov/pubmed/37303932
http://dx.doi.org/10.5498/wjp.v13.i5.182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251361/
https://www.ncbi.nlm.nih.gov/pubmed/37303932
http://dx.doi.org/10.5498/wjp.v13.i5.182

Ejemplares similares